Patents by Inventor Alexander H. Glassman

Alexander H. Glassman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking
    Patent number: 4783456
    Abstract: In human subjects accustomed to smoking tobacco the withdrawal symptoms associated with the cessation or reduction of tobacco smoking may be prevented by administering to the subject an effective amount of an alpha-2 adrenergic agonist such as clonidine hydrochloride for a suitable period of time.Alternatively, such withdrawal symptoms may be prevented by administering to such a person an effective amount of alprazolam.
    Type: Grant
    Filed: June 12, 1987
    Date of Patent: November 8, 1988
    Assignee: Research Foundation for Mental Hygiene, Inc.
    Inventor: Alexander H. Glassman
  • Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking
    Patent number: 4683231
    Abstract: In human subjects accustomed to smoking tobacco the withdrawal symptoms associated with the cessation or reduction of tobacco smoking may be prevented by administering to the subject an effective amount of an alpha-2 adrenergic agonist such as clonidine hydrochloride for a suitable period of time.Alternatively, such withdrawal symptoms may be prevented by administering to such a person an effective amount of alprazolam.
    Type: Grant
    Filed: April 16, 1986
    Date of Patent: July 28, 1987
    Assignee: Research Foundation for Mental Hygiene, Inc.
    Inventor: Alexander H. Glassman
  • Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking
    Patent number: 4588739
    Abstract: In human subjects accustomed to smoking tobacco the withdrawal symptoms associated with the cessation or reduction of tobacco smoking may be prevented by administering to the subject an effective amount of an alpha-2 adrenergic agonist such as clonidine hydrochloride for a suitable period of time.Alternatively, such withdrawal symptoms may be prevented by administering to such a person an effective amount of alprazolam.
    Type: Grant
    Filed: March 2, 1984
    Date of Patent: May 13, 1986
    Assignee: Research Foundation for Mental Hygiene, Inc.
    Inventor: Alexander H. Glassman